Results 41 to 50 of about 68,420 (313)
Radiation-associated sarcoma of the skull base after irradiation for pituitary adenoma
Rare Tumors, 2012 Secondary, radiation-induced neoplasms represent a significant long-term risk after radiation treatment, and radiation-induced sarcomas (RAS) have an especially poor prognosis. These have rarely been reported after irradiation for pituitary adenomas.
Cara L. Sedney +4 more
doaj +1 more source
Frontiers in Endocrinology, 2021 Granular cell tumors of the pituitary belong to a rare family of neoplasms, arising from the posterior pituitary gland. Although considered benign, they may cause significant morbidity and residual disease after resection can lead to poor clinical ...
Christopher S. Hong +7 more
doaj +1 more source
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors [PDF]
, 2016 PURPOSE: Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses ...
Agar, Nathalie Y. R. +13 more
core +3 more sources
Treatment of pituitary neoplasms with temozolomide [PDF]
Cancer, 2010 AbstractTemozolomide, an orally administered alkylating agent, is used to treat malignant gliomas. Recent reports also have documented its efficacy in the treatment of pituitary adenomas and carcinomas. Temozolomide methylates DNA and thereby exhibits an antitumor effect.
Luis V, Syro +9 more
openaire +2 more sources
The evolution in pituitary tumour classification: a clinical perspective
Endocrine Oncology, 2023 Objective: Pituitary tumours comprise a pathologically and clinically diverse group of neoplasms. Classification frameworks have changed dramatically in the past two decades, reflecting improving understanding of tumour biology.
Nele F Lenders +3 more
doaj +1 more source
A case report of a rare intramuscular granular cell tumor [PDF]
, 2015 Background: Granular cell tumors (GCTs) were firstly described by Weber in 1854 and 70 years later by Abrikossoff and classified as benign tumors. Originally considered muscle tumors, they have been identified as neural lesions, due to their close ...
Cacciotti, Jessica +8 more
core +1 more source
International Journal of Endocrinology, 2015 Pituitary adenomas, monoclonal in origin, are the most common intracranial neoplasms. Altered gene expression as well as somatic mutations is detected frequently in pituitary adenomas.
Peng Zhao +7 more
doaj +1 more source
Alʹmanah Kliničeskoj Mediciny, 2018 Multiple endocrine neoplasia syndrome type 1 (MEN1, Wermer's syndrome) is a group of heterogeneous inherited diseases, with its pathogenesis related to hyperplasia or neoplasms of several endocrine glands.
L. Ya. Rozhinskaya +7 more
doaj +1 more source
Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Alʹmanah Kliničeskoj Mediciny, 2022 Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin +3 more
doaj +1 more source
DiagnosticsBackground: Pituitary adenomas represent the most common pituitary disorder, with an estimated prevalence as high as 20%, and they can manifest with hormone hypersecretion or deficiency, neurological symptoms from mass effect, or incidental findings on ...
Janez Ravnik +8 more
doaj +1 more source